Independent fund research. Built on SEC filings.

How we research funds

ETF overlap

RSPH vs RYHIX overlap: 21% of top holdings shared

Bottom line

How much do RSPH and RYHIX overlap?

21% of their top holdings overlap by weight. 6 securities appear in both funds' top 25, making up 11.0% of RSPH's assets and 9.2% of RYHIX's. They are substantially different portfolios, so owning both adds real diversification.

RYHIX holds far more positions (135 vs 63), so it is broader beyond the top names.

Updated Nov 22, 2026

Overlap at a glance

RSPHRYHIX
Weight overlap (top 25)21%
Shared holdings6
Weight in shared holdings11.0%9.2%
Total positions63135
Expense ratio0.4%1.38%
Holdings as ofJul 31, 2026Jun 30, 2026

Source: SEC Form N-PORT (periods Jul 31, 2026 / Jun 30, 2026)

Holdings RSPH and RYHIX have in common

Holding% of RSPH% of RYHIXOverlap
Regeneron Pharmaceuticals, Inc.1.96%0.90%0.90%
Thermo Fisher Scientific Inc.1.84%1.61%1.61%
Abbott Laboratories1.83%1.42%1.42%
Bristol-Myers Squibb Co.1.82%1.22%1.22%
Amgen Inc.1.77%1.56%1.56%
AbbVie Inc.1.73%2.52%1.73%

Source: SEC Form N-PORT (periods Jul 31, 2026 / Jun 30, 2026)

Free weekly newsletter

The Fund Letter

Get fee cuts and hikes, fund closures and mergers, and one plain-English idea to make your portfolio cheaper — every week.

Free. Unsubscribe anytime. We never sell your email.

What each fund holds that the other doesn't

Top-25 holdings that appear in only one of the two funds' top 25.

Only in RSPH

  1. Bio-Techne Corp. — 2.13%
  2. IQVIA Holdings Inc. — 2.00%
  3. Baxter International Inc. — 1.99%
  4. Mettler-Toledo International Inc. — 1.94%
  5. Charles River Laboratories International, Inc. — 1.93%
  6. Veeva Systems Inc. — 1.93%
  7. DaVita Inc. — 1.87%
  8. Moderna, Inc. — 1.85%
  9. Universal Health Services, Inc. — 1.80%
  10. Labcorp Holdings Inc. — 1.78%
  11. Quest Diagnostics Inc. — 1.77%
  12. Incyte Corp. — 1.76%
  13. Becton, Dickinson and Co. — 1.73%
  14. DexCom, Inc. — 1.73%
  15. Viatris Inc. — 1.72%

Only in RYHIX

  1. Eli Lilly & Company — 3.63%
  2. Johnson & Johnson — 2.88%
  3. Unitedhealth Group Inc — 2.22%
  4. Merck & Company Inc — 2.04%
  5. Gilead Sciences Inc — 1.39%
  6. Vertex Pharmaceuticals Inc — 1.34%
  7. Cvs Health Corp — 1.31%
  8. Intuitive Surgical Inc — 1.31%
  9. Danaher Corp — 1.30%
  10. Pfizer Inc — 1.25%
  11. Stryker Corp — 1.21%
  12. Mckesson Corp — 1.05%
  13. Elevance Health Inc — 1.02%
  14. Cigna Group (the) — 0.94%
  15. Hca Healthcare Inc — 0.87%

Asset mix

Asset typeRSPHRYHIX
Stocks99.9%83.2%
Cash & short-term funds2.3%—
Repurchase agreements—0.9%

Source: SEC Form N-PORT (periods Jul 31, 2026 / Jun 30, 2026)

Country mix

CountryRSPHRYHIX
US98.9%73.0%
IE3.4%3.3%
CH—2.3%
GB—1.8%
DK—1.4%
NL—0.7%
IL—0.6%
DE—0.6%

Source: SEC Form N-PORT (periods Jul 31, 2026 / Jun 30, 2026)

Check another pair

FAQ

How much do RSPH and RYHIX overlap?
About 21% by weight. 6 securities appear in both funds' top 25 holdings; they make up 11.0% of RSPH's assets and 9.2% of RYHIX's. They are substantially different portfolios, so owning both adds real diversification.
What stocks do RSPH and RYHIX have in common?
The largest shared holdings are AbbVie Inc., Thermo Fisher Scientific Inc., Amgen Inc., Abbott Laboratories, Bristol-Myers Squibb Co..
Should I own both RSPH and RYHIX?
Their portfolios are mostly different, so owning both can add diversification. Check how each fits your overall allocation.
Which holds more stocks, RSPH or RYHIX?
RYHIX is broader, with 135 positions versus 63 for RSPH. Overlap here is measured on each fund's top 25 holdings, which carry most of the weight.

Overlap is computed from each fund's top 25 holdings in its latest SEC Form N-PORT filing, with weights normalized to the top 25; for each shared security we count the smaller of the two weights. Educational information, not investment advice.